Amgen outlines raised 2026 guidance of $38.2B-$39.4B revenue and $22.30-$23.50 non-GAAP EPS as CFO transition nears

EarningsPositive

AI Analysis

Summary

Amgen raised its 2026 financial guidance with revenue expected between $38.2B-$39.4B and non-GAAP EPS of $22.30-$23.50, ahead of a CFO transition at the company.

Financial Highlights

Revenue

$38.2B-$39.4B

EPS

$22.30-$23.50 non-GAAP

Guidance

2026 revenue guidance raised to $38.2B-$39.4B; non-GAAP EPS guidance raised to $22.30-$23.50

Importance:6/10

Sentiment:

0.70

guidanceearningsCFO transition

Related Companies

$AMGN

Read the original article

Published by Seeking Alpha Healthcare on August 5, 2026 3:21 AM

Read Original